Accueil / Tag Archives: Product/Service

Tag Archives: Product/Service

CHMP positive opinion to include RE-CIRCUIT® data for atrial fibrillation patients undergoing catheter ablation in Pradaxa® Summary of Product Characteristics

Monday, September 18th 2017 at 7:08am UTC The CHMP of the EMA has issued a positive opinion for an update of the Summary of Product Characteristics (SmPC) for Pradaxa® (dabigatran etexilate) The CHMP recommends to include data showing that catheter ablation can be conducted in patients on 150 mg twice …

Plus »

Contagion® Launches First Peer Exchange on Lyme Disease

Wednesday, September 20th 2017 at 3:17pm UTC The broadcast features renowned Lyme disease experts CRANBURY, N.J.–(BUSINESS WIRE)– Contagion®, the nation’s leading digital and print publication that provides practitioners and specialists working in the infectious disease field with disease-specific information, unveiled its first Peer Exchange, a lively conversation between medical experts …

Plus »

IDbyDNA and ARUP Laboratories Introduce Explify Respiratory: Breakthrough Technology to Diagnose Pneumonia Caused by Previously Undetected Pathogens

Tuesday, September 19th 2017 at 11:30am UTC Metagenomics test identified pathogens missed by conventional lab tests in 44 percent of immunocompromised children treated for respiratory infection SAN FRANCISCO & SALT LAKE CITY–(BUSINESS WIRE)– ARUP Laboratories and IDbyDNA, Inc., a data analytics-driven metagenomics company, announce the launch of Explify™ Respiratory, a …

Plus »

InGeneron Announces Publication of Positive Results from Investigator-Initiated Wound Healing Case Series Using Company’s Regenerative Cell Technology

Monday, September 18th 2017 at 10:00am UTC Point-of-care regenerative cell therapy demonstrates promising safety and tolerability profile and closure of venous chronic leg wounds as conducted by Technical University Munich HOUSTON, Texas & MUNICH–(BUSINESS WIRE)– InGeneron, Inc., a regenerative medicine and biotechnology company, today announced the publication of results from …

Plus »

Merck to Advance Bispecific Antibody Drug Candidate Developed Using Zymeworks’ Azymetric™ Platform into Preclinical Development

Tuesday, September 19th 2017 at 9:00am UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (“Zymeworks”), (NYSE: ZYME; TSX: ZYME) a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation bispecific and multifunctional biotherapeutics, today announced that Merck (known as MSD outside the US and Canada) has provided formal …

Plus »

Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery

Tuesday, September 19th 2017 at 3:00pm UTC Strategic Sponsorship Will Provide Innovative Technology and Nurture Promising Biotechnology Startup SANTA CLARA, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) has announced a platinum sponsorship agreement with LabCentral, a biotech innovation hub based in Cambridge, Massachusetts. LabCentral is an independent, …

Plus »

FDA Grants “Fast Track” Status to Cancer Prevention Pharmaceuticals’ Lead Drug CPP-1X/sul for Treatment of Familial Adenomatous Polyposis

Monday, September 18th 2017 at 9:30am UTC CPP-1X/sul aims to prevent disease progression in patients with Familial Adenomatous Polyposis TUCSON, Ariz.–(BUSINESS WIRE)– Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced today that the U.S. Food and Drug Administration (FDA) …

Plus »

Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT® in Patients at High Risk of Recurrent Renal Cell Carcinoma after Surgery

Tuesday, September 19th 2017 at 5:15pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory Committee (ODAC) voted 6 in favor and 6 against the benefit-risk profile for SUTENT® (sunitinib) as adjuvant treatment of adult patients at high risk …

Plus » Partners with Top Pharma to Launch COMPLI™, a Global Compliance Standard for Human Biosample Acquisition

Thursday, September 21st 2017 at 12:06pm UTC Sourcing of high-risk services made easier with’s new COMPLI™ feature SAN DIEGO–(BUSINESS WIRE)–, the world’s leading marketplace for outsourced scientific services, today announced the launch of a global process for the ethical sourcing of human biosamples using its COMPLI™ functionality. Created …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
Retrouvez nous sur
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...